This inventor holds 30 USPTO granted patents and 32 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Gene Editing Technologies. Top assignees: Massachusetts Institute of Technology, The Broad Institute, Inc., Harvard College. Active years: 2017-2026.
Location History:
- Gloucester, MA (US) (2017 - 2023)
- Cambridge, MA (US) (2019 - 2024)
Company Filing History:
22 out of 8,576 
22 out of 482 
14 out of 3,071 
Years Active: 2017-2026
Areas of Expertise:
Title: The Innovative Mind of Bernd Zetsche: Revolutionizing Nucleic Acid Editing
Introduction:
Bernd Zetsche, a visionary inventor based in Gloucester, MA, has made a significant impact in the field of molecular biology and gene editing. With an impressive portfolio of 17 patents, Zetsche is renowned for his groundbreaking work in targeted nucleic acid editing.
Latest Patents:
Zetsche's latest patents showcase his expertise in developing cutting-edge systems for targeted nucleic acid editing. One of his recent inventions includes systems, methods, and compositions for precise nucleic acid editing using engineered DNA-targeting systems comprising a DNA-targeting Cpf1 protein, guide molecules, and adenosine deaminase proteins. Additionally, Zetsche's work in CRISPR enzymes and systems has paved the way for novel DNA-targeting CRISPR effector proteins, revolutionizing the landscape of gene editing technologies.
Career Highlights:
Throughout his career, Bernd Zetsche has been affiliated with esteemed institutions such as the Massachusetts Institute of Technology (MIT) and The Broad Institute, Inc. His contributions at these renowned research institutions have been instrumental in advancing the field of molecular biology and genetic engineering. Zetsche's dedication to innovation and scientific excellence has earned him recognition as a trailblazer in nucleic acid editing technology.
Collaborations:
Zetsche's collaborative efforts with notable peers such as Feng Zhang and Ian Slaymaker have further solidified his reputation as a pioneering inventor. By working alongside leading experts in the field, Zetsche has been able to exchange ideas, push boundaries, and drive forward groundbreaking research that has the potential to revolutionize the way we approach gene editing and molecular biology.
Conclusion:
In conclusion, Bernd Zetsche's relentless pursuit of innovation and his commitment to pushing the boundaries of nucleic acid editing have cemented his status as a visionary inventor in the field of molecular biology. His latest patents are a testament to his technical prowess and his unwavering dedication to advancing scientific knowledge. As he continues to break new ground and inspire future generations of inventors, Bernd Zetsche stands as a shining example of creativity and ingenuity in the realm of gene editing technologies.